Nuvation Bio Inc.
NYSE:NUVB
2.1 (USD) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 35.723 | 42.649 | 101.099 | 132.423 | 29.755 | 3.469 | 0.138 |
| Short Term Investments
| 466.969 | 568.564 | 559.915 | 632.969 | 185.997 | 115.401 | 0 |
| Cash and Short Term Investments
| 502.692 | 611.213 | 661.014 | 765.392 | 215.752 | 118.87 | 0.138 |
| Net Receivables
| 16.292 | 3.702 | 2.485 | 3.039 | 1.092 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 2.925 | 0 | 0 |
| Other Current Assets
| 7.271 | 1.519 | 3.819 | 3.642 | 3.839 | 1.015 | 0.02 |
| Total Current Assets
| 526.255 | 616.434 | 667.318 | 772.073 | 220.683 | 119.885 | 0.158 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 2.988 | 4.322 | 4.685 | 3.657 | 0.688 | 0.646 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 4.622 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 4.622 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | -559.355 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 6.761 | 0.728 | 559.493 | 0.421 | 0.421 | 0.421 | 0 |
| Total Non-Current Assets
| 14.371 | 5.05 | 4.823 | 4.078 | 1.109 | 1.067 | 0 |
| Total Assets
| 540.626 | 621.484 | 672.141 | 776.151 | 221.792 | 120.952 | 0.158 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 6.348 | 2.209 | 2.139 | 3.925 | 2.171 | 2.03 | 0.083 |
| Short Term Debt
| 7.946 | 1.972 | 2.412 | 1.726 | 0 | 0 | 0.6 |
| Tax Payables
| 0.679 | 0.144 | 0.112 | 0.402 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 43.271 | 9.649 | 8.498 | 10.872 | 4.38 | 1.174 | 0.219 |
| Total Current Liabilities
| 58.244 | 13.974 | 13.161 | 16.925 | 6.551 | 3.204 | 0.902 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 0 | 2.035 | 3.054 | 2.192 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 18.594 | 0.353 | 0.85 | 11.037 | 0.157 | 0 | 0 |
| Total Non-Current Liabilities
| 18.594 | 2.388 | 3.904 | 13.229 | 0.157 | 0 | 0 |
| Total Liabilities
| 76.838 | 16.362 | 17.065 | 30.154 | 6.708 | 3.204 | 0.902 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 141.864 | 0 |
| Common Stock
| 1,373.958 | 947.745 | 927.604 | 909.985 | 289.482 | 9.759 | 0 |
| Retained Earnings
| -910.743 | -342.804 | -267.002 | -162.803 | -75.955 | -34.296 | -0.744 |
| Accumulated Other Comprehensive Income/Loss
| 0.573 | 0.181 | -5.526 | -1.185 | 1.557 | 0.421 | 0 |
| Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Shareholders Equity
| 463.788 | 605.122 | 655.076 | 745.997 | 215.084 | 117.748 | -0.744 |
| Total Equity
| 463.788 | 605.122 | 655.076 | 745.997 | 215.084 | 117.748 | -0.744 |
| Total Liabilities & Shareholders Equity
| 540.626 | 621.484 | 672.141 | 776.151 | 221.792 | 120.952 | 0.158 |